Correlation Between NewAmsterdam Pharma and In8bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and In8bio Inc, you can compare the effects of market volatilities on NewAmsterdam Pharma and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and In8bio.

Diversification Opportunities for NewAmsterdam Pharma and In8bio

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between NewAmsterdam and In8bio is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and In8bio go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and In8bio

Assuming the 90 days horizon NewAmsterdam Pharma is expected to generate 1.56 times more return on investment than In8bio. However, NewAmsterdam Pharma is 1.56 times more volatile than In8bio Inc. It trades about 0.07 of its potential returns per unit of risk. In8bio Inc is currently generating about 0.08 per unit of risk. If you would invest  870.00  in NewAmsterdam Pharma on September 1, 2024 and sell it today you would earn a total of  36.00  from holding NewAmsterdam Pharma or generate 4.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  In8bio Inc

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
In8bio Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days In8bio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

NewAmsterdam Pharma and In8bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and In8bio

The main advantage of trading using opposite NewAmsterdam Pharma and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.
The idea behind NewAmsterdam Pharma and In8bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments